,drug_name,section_name,gpt_output
0,KYPROLIS,adverse reactions,"Cardiac Toxicities, Acute Renal Failure, Tumor Lysis Syndrome, Pulmonary Toxicity, Pulmonary Hypertension, Dyspnea, Hypertension, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic Thrombocytopenic Purpura, Hemolytic Uremic Syndrome, Posterior Reversible Encephalopathy Syndrome (PRES), anemia, fatigue, nausea, pyrexia, decreased platelets, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, constipation, asthenia, nasopharyngitis, bronchitis, pneumonia, hypocalcemia, hyperglycemia, muscle spasms, peripheral neuropathies NEC, insomnia, rash, embolic and thrombotic events, venous, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, myocardial infarction, myocardial ischemia, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal failure acute, renal impairment, dysphonia, epistaxis, oropharyngeal pain, pulmonary embolism, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, decreased appetite, hypercalcemia, back pain, arthralgia, pain in extremity, musculoskeletal pain, headache, dizziness, peripheral neuropathies NEC, insomnia, dyspnea, epistaxis, renal failure, hypertension, dehydration, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS), tumor lysis syndrome, posterior reversible encephalopathy syndrome (PRES), death"
1,KYPROLIS,warnings and precautions,"cardiac failure, myocardial infarction, fatal outcome <death>, myocardial ischemia, Acute Renal Failure, Tumor Lysis Syndrome, Acute Respiratory Distress Syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, Pulmonary Hypertension, Dyspnea, Hypertension, hypertensive crisis, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, Posterior reversible encephalopathy syndrome, Embryo-fetal Toxicity, congestive heart failure, pulmonary edema, decreased ejection fraction, restrictive cardiomyopathy, cardiac arrest, renal impairment, renal failure, pneumonitis, interstitial lung disease, Pulmonary arterial hypertension, deep venous thrombosis, pulmonary embolism, fever, chills, arthralgia, myalgia, facial flushing, facial edema, vomiting, weakness, shortness of breath, hypotension, syncope, chest tightness, angina, increased serum transaminases, seizure, headache, lethargy, confusion, blindness, altered consciousness, visual disturbances, neurological disturbances, embryo-fetal toxicity"
2,MULTAQ,adverse reactions,"new or worsening heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, bradycardia, rashes, pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, early increases in creatinine >=10%, QTc prolonged, atrial flutter with 1:1 atrioventricular conduction, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis"
3,MULTAQ,boxed warnings,"death, stroke, heart failure"
4,MULTAQ,warnings and precautions,"cardiac rhythm abnormalities, atrial fibrillation (AF) <negated>, liver injury, hepatic injury, pulmonary toxicity, hypokalemia, hypomagnesemia, renal impairment, teratogen, cardiovascular death, heart failure, stroke, new onset heart failure, worsening heart failure, hepatocellular liver injury, acute liver failure, interstitial lung disease, pneumonitis, pulmonary fibrosis, dyspnea, non-productive cough, QT interval prolongation, marked increase in serum creatinine, pre-renal azotemia, acute renal failure, small increases in creatinine levels, fetal harm, death"
5,JUBLIA,adverse reactions,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
6,TEFLARO,adverse reactions,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, hypersensitivity <negated>, death, constipation, vomiting, increased transaminases, hypokalemia, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis"
7,TEFLARO,warnings and precautions,"serious hypersensitivity reactions, anaphylactic reactions, Clostridium difficile-associated diarrhea (CDAD), fatal colitis, death, Direct Coombs' test seroconversion, drug-induced hemolytic anemia, development of drug-resistant bacteria"
8,DATSCAN,adverse reactions,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, injection site pain"
9,DATSCAN,warnings and precautions,"Hypersensitivity reactions, anaphylactic <negated>, hypersensitivity treatment measures <negated>, skin erythema, pruritis, corticosteroids <negated>, anti-histamines <negated>, hypersensitivity reaction to DaTscan <negated>, thyroid accumulation <negated>, thyroid neoplasia."
10,TIVICAY,adverse reactions,"Hypersensitivity reactions, Effects on serum liver biochemistries, Fat Redistribution, Immune Reconstitution Syndrome, insomnia, fatigue, headache, Treatment-emergent Adverse Drug Reactions, nausea, diarrhea, rash <negated>, abnormal dreams <negated>, dizziness <negated>, depression <negated>, vertigo <negated>, Abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, Hepatitis, Myositis, Suicidal ideation <negated>, attempt <negated>, behavior <negated>, completion <negated>, Renal impairment, Pruritus, ALT abnormalities, AST abnormalities, Creatine kinase abnormalities, Hyperglycemia, Lipase abnormalities, Total neutrophils abnormalities, Cholesterol changes, HDL cholesterol changes, LDL cholesterol changes, Triglycerides changes, elevated ALT, elevated AST, elevated cholesterol, elevated creatine kinase, hyperglycemia, elevated lipase, neutropenia, Grades 2 to 4 ALT abnormalities, Serum Creatinine increase, rash, abdominal pain, diarrhea, elevated total bilirubin, elevated lipase, changes in mean serum creatinine, death"
11,TIVICAY,warnings and precautions,"hypersensitivity reactions, rash, constitutional findings, organ dysfunction, liver injury, transaminase elevations, hepatotoxicity, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome, severe rash, fever, general malaise, fatigue, muscle or joint aches, blisters, peeling of the skin, oral blisters, lesions, conjunctivitis, facial edema, hepatitis, eosinophilia, angioedema, difficulty breathing, death"
12,TAFINLAR,adverse reactions,"New Primary Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, back pain, myalgia, cuSCC, cough, constipation, nasopharyngitis, hypophosphatemia, increased alkaline phosphatase, hyponatremia, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased alkaline phosphatase, increased ALT, hyperbilirubinemia, increased GGT, hypoalbuminemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QT Prolongation, death"
13,TAFINLAR,warnings and precautions,"Retinal vein occlusion, Interstitial lung disease, New primary malignancies, cutaneous, New primary malignancies, non-cutaneous, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Major hemorrhagic events, Venous Thromboembolism, Deep vein thrombosis, Pulmonary embolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, Embryofetal Toxicity, Cutaneous squamous cell carcinoma, Keratoacanthoma, Melanoma, Basal cell carcinoma, Pancreatic adenocarcinoma, Colorectal carcinoma, Head and neck carcinoma, Glioblastoma, Intracranial hemorrhage, Gastric hemorrhage, Retinal Pigment Epithelial Detachment (RPED), Uveitis, Iritis, Pyrexia, Hypotension, Rigors, Chills, Dehydration, Renal failure, Hemolytic anemia, Teratogenic effects, Embryotoxic effects, death"
14,HORIZANT,adverse reactions,"somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, asthenia, insomnia, breast enlargement, gynecomastia, elevated creatine kinase"
15,HORIZANT,warnings and precautions,"Driving impairment, Somnolence/sedation, Dizziness, Suicidal thoughts or behaviors, Fatigue/asthenia, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Multiorgan hypersensitivity, Fever, Rash, Lymphadenopathy, Hepatitis, Nephritis, Hematological abnormalities, Myocarditis, Myositis, Eosinophilia, Withdrawal seizure, Pancreatic acinar cell adenoma, Pancreatic acinar cell carcinoma, Tumorigenic potential, death"
16,IMBRUVICA,adverse reactions,"Hemorrhage, Infections, Cytopenias, Atrial Fibrillation, Second Primary Malignancies, Tumor Lysis Syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, skin infections, pyrexia, asthenia, petechiae, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, stomatitis, dyspepsia, sinusitis, urinary tract infection, chills, laceration, anxiety, insomnia, hypertension, vision blurred, contusion, oropharyngeal pain, peripheral neuropathy, second malignancies, pruritus, arthropathy, skin cancer, renal failure <negated>, subdural hematoma, lymphocytosis <negated>, hyperuricemia, intracranial hemorrhage <negated>, lethargy <negated>, gait instability <negated>, elevated uric acid levels, hypersensitivity reactions, anaphylactic shock, urticaria, angioedema, death"
17,IMBRUVICA,warnings and precautions,"hemorrhage, bleeding, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, bruising, petechiae, death, infections, fever, Grade 3 or greater infections, progressive multifocal leukoencephalopathy (PML), cytopenias, neutropenia, thrombocytopenia, anemia, atrial fibrillation, atrial flutter, arrhythmic symptoms, palpitations, lightheadedness, dyspnea, second primary malignancies, non-skin carcinomas, non-melanoma skin cancer, tumor lysis syndrome, embryo-fetal toxicity, fetal harm, malformations, reduced fetal weights"
18,ULORIC,adverse reactions,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis, leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis, cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms, muscle twitching, muscle tightness, muscle weakness, musculoskeletal pain, musculoskeletal stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration, altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, hepatic failure <negated>, jaundice, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior, aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions, death"
19,ULORIC,warnings and precautions,"gout flare, cardiovascular thromboembolic events, cardiovascular deaths, non-fatal myocardial infarctions, non-fatal strokes, hepatic failure, fatal hepatic failure <negated>, non-fatal hepatic failure, transaminase elevations, AST elevation, ALT elevation, liver injury, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice, severe drug-induced liver injury, death"
20,CIMZIA,adverse reactions,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, thrombophlebitis, vasculitis, headache, hypertension, back pain, pharyngitis, acute bronchitis, fatigue, herpes infections, lower respiratory tract infections, cellulitis, pyelonephritis, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis, death"
21,CIMZIA,boxed warnings,"serious infections, hospitalization, death, methotrexate <negated>, corticosteroids <negated>, sepsis, active tuberculosis, reactivation of latent tuberculosis, disseminated disease, extrapulmonary disease, latent tuberculosis, invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, infections due to opportunistic pathogens, Legionella, Listeria, chronic infection <negated>, recurrent infection <negated>, tuberculosis, bacterial sepsis, lymphoma, malignancies"
22,CIMZIA,warnings and precautions,"serious infections, invasive fungal infections, lymphoma, malignancies, heart failure, anaphylaxis, serious allergic reactions, hepatitis B virus reactivation, demyelinating disease, cytopenias, pancytopenia, lupus-like syndrome, tuberculosis, opportunistic infections, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, chronic infection, recurrent infection, worsening congestive heart failure, new onset congestive heart failure, hypersensitivity reactions, angioedema, dyspnea, hypotension, rash, serum sickness, urticaria, neurologic reactions, seizure disorder, optic neuritis, peripheral neuropathy, Guillain-Barre syndrome, aplastic anemia, leukopenia, thrombocytopenia, blood dyscrasias, infection, bruising, bleeding, pallor, death"
23,KALYDECO,adverse reactions,"headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, increased hepatic enzymes, hypoglycemia, rhinitis, arthralgia, bacteria in sputum, aspartate aminotransferase increased, blood glucose increased, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne, transaminase elevations, elevated liver transaminases, death"
24,KALYDECO,warnings and precautions,"elevated transaminases, increased transaminase levels, non-congenital lens opacities, cataracts"
25,FULYZAQ,adverse reactions,"upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count"
26,FULYZAQ,warnings and precautions,"infectious diarrhea, disease may worsen, death"
27,QUTENZA,adverse reactions,"application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor"
28,QUTENZA,warnings and precautions,"coughing, sneezing, irritation of eyes, irritation of airway, transient increases in blood pressure, procedural pain, increases in blood pressure, adverse cardiovascular effects"
29,GRANIX,adverse reactions,"Splenic Rupture, Acute Respiratory Distress Syndrome, Serious Allergic Reactions, Capillary Leak Syndrome, Potential for Tumor Growth Stimulatory Effects on Malignant Cells, bone pain, Leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia"
30,GRANIX,warnings and precautions,"Splenic Rupture, Acute Respiratory Distress Syndrome (ARDS), allergic reactions, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, Sickle cell crisis, death, Capillary Leak Syndrome (CLS), hypotension, hypoalbuminemia, edema, hemoconcentration, anaphylaxis, Tumor Growth Stimulatory Effects on Malignant Cells."
31,COARTEM,adverse reactions,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, malaria, nasopharyngitis, Plasmodium falciparum infection, rhinitis, Aspartate aminotransferase increased, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, serious skin reactions (bullous eruption)"
32,COARTEM,warnings and precautions,"QT prolongation, hypokalemia, hypomagnesemia, symptomatic cardiac arrhythmias, clinically relevant bradycardia, severe cardiac disease, sudden death, disturbances of electrolyte balance, decreased exposure to lumefantrine, decreased efficacy, potentiate QT prolongation, loss of antimalarial efficacy, reduced effectiveness of hormonal contraceptives, increased risk of adverse effects, recrudescence, severe hepatic impairment <negated>, severe renal impairment <negated>, relapsing malaria, death"
33,APTIOM,adverse reactions,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, Anaphylactic Reactions, Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, asthenia, rash, dysarthria, gait disturbance, peripheral edema, urinary tract infections, fall, balance disorder, memory impairment, nystagmus, depression, insomnia, cough, hypertension, decreases in hemoglobin, decreases in hematocrit, increases in total cholesterol, increases in triglycerides, increases in LDL, increases in creatine phosphokinase"
34,APTIOM,warnings and precautions,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Anaphylactic Reactions, Angioedema, Hyponatremia, Neurological Adverse Reactions, dizziness, disturbance in gait and coordination, somnolence, fatigue, cognitive dysfunction, visual changes, Withdrawal of APTIOM, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), Multiorgan Hypersensitivity, fever, rash, lymphadenopathy, hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, eosinophilia, laryngeal edema, seizures, severe nausea/vomiting, dehydration, severe gait instability, injury, hypochloremia, ataxia, vertigo, balance disorder, gait disturbance, nystagmus, abnormal coordination, fatigue, asthenia, malaise, hypersomnia, sedation, lethargy, memory impairment, disturbance in attention, amnesia, confusional state, aphasia, speech disorder, slowness of thought, disorientation, psychomotor retardation, diplopia, blurred vision, impaired vision, increased seizure frequency, status epilepticus, elevations in transaminases, jaundice, serum T3 and T4 decreases, death (due to mention of fatal events)."
35,PROLIA,adverse reactions,"hypocalcemia, serious infections, dermatologic adverse reactions, osteonecrosis of the jaw, atypical subtrochanteric and diaphyseal femoral fractures, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, pancreatitis, new malignancies, cataracts, death, drug-related hypersensitivity reactions, anaphylaxis, rash, urticaria, facial swelling, erythema, severe symptomatic hypocalcemia, severe musculoskeletal pain, marked elevation in serum PTH"
36,PROLIA,warnings and precautions,"hypersensitivity, anaphylactic reactions, hypocalcemia, osteonecrosis of the jaw, atypical femoral fractures, serious infections, skin infections, hospitalization, cellulitis, dermatologic reactions, dermatitis, rashes, eczema, severe bone pain, joint pain, muscle pain, suppression of bone turnover, hypotension, dyspnea, throat tightness, facial and upper airway edema, pruritus, urticaria, mineral metabolism disturbances, marked elevations of serum parathyroid hormone (PTH), invasive dental procedures, oral surgery, poor oral hygiene, co-morbid disorders, periodontal disease, dental disease, anemia, coagulopathy, infection, ill-fitting dentures, abdominal infections, urinary tract infections, ear infections, endocarditis, opportunistic infections, epidermal adverse events, dermal adverse events, incapacitating bone pain, incapacitating joint pain, incapacitating muscle pain, bone remodeling suppression, bone turnover markers, bone histomorphometry, osteonecrosis, delayed fracture healing, thigh pain, groin pain, hip pain, prodromal pain, dull pain, aching pain, bilateral fractures, glucocorticoid treatment, prednisone treatment, immunosuppressant agents, impaired immune systems, severe infection signs, severe infection symptoms, injection site reactions, bone turnover suppression, long-term treatment consequences, adverse outcomes, atypical fractures, fracture healing."
37,BLINCYTO,adverse reactions,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, pyrexia, headache, peripheral edema, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, infection, overdose, confusion, Staphylococcal bacteremia, anemia, thrombocytopenia, leukopenia, diarrhea, abdominal pain, vomiting, fatigue, chills, chest pain, cytokine release syndrome, other pathogen infections, bacterial infections, fungal infections, viral infections, increased alanine aminotransferase, increased aspartate aminotransferase, increased weight, hypomagnesemia, hyperglycemia, decreased appetite, hypophosphatemia, back pain, pain in extremity, bone pain, arthralgia, dizziness, insomnia, cough, dyspnea, hypotension, hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, tumor lysis syndrome, hypoalbuminemia, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm, death."
38,BLINCYTO,boxed warnings,"Cytokine Release Syndrome, Neurological toxicities, life-threatening <negated>, fatal <negated>, death"
39,BLINCYTO,warnings and precautions,"Infections, Cytokine Release Syndrome (CRS), Infusion reactions, Pyrexia, Headache, Nausea, Asthenia, Hypotension, Increased alanine aminotransferase, Increased aspartate aminotransferase, Increased total bilirubin, Disseminated intravascular coagulation (DIC), Capillary leak syndrome (CLS), Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), Neurological toxicities, Encephalopathy, Convulsions, Speech disorders, Disturbances in consciousness, Confusion and disorientation, Coordination and balance disorders, Sepsis, Pneumonia, Bacteremia, Opportunistic infections, Catheter-site infections, Tumor Lysis Syndrome (TLS), Neutropenia, Febrile neutropenia, Seizures, Elevated liver enzymes, Transient elevations in liver enzymes, Grade 3 or greater elevations in liver enzymes, Leukoencephalopathy, Preparation and administration errors, death (associated with life-threatening or fatal events mentioned)."
40,STENDRA,adverse reactions,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection (URI), bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, upper respiratory infection, electrocardiogram abnormal, dizziness, gastroenteritis viral, non-arteritic anterior ischemic optic neuropathy (NAION)"
41,STENDRA,warnings and precautions,"hypotension, erection lasting greater than 4 hours, sudden loss of vision, Non Arteritic Ischemic Optic Neuropathy (NAION), sudden decrease or loss of hearing, tinnitus, dizziness, headache, myocardial infarction <negated>, stroke <negated>, life-threatening arrhythmia <negated>, coronary revascularization <negated>, resting hypotension <negated>, hypertension <negated>, unstable angina <negated>, angina with sexual intercourse <negated>, congestive heart failure <negated>, priapism, penile tissue damage, permanent loss of potency, anatomical deformation of the penis, angulation <negated>, cavernosal fibrosis <negated>, Peyronie's disease <negated>, sickle cell anemia <negated>, multiple myeloma <negated>, leukemia <negated>, symptomatic hypotension, lightheadedness, fainting, orthostatic signs and symptoms, increase in heart rate, decrease in standing blood pressure, bleeding disorders <negated>, active peptic ulceration <negated>, sexually transmitted diseases <negated>, Human Immunodeficiency Virus (HIV) <negated>."
42,XIAFLEX,adverse reactions,"Tendon ruptures, serious injury to the injected extremity, Corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral (e.g., swelling of the injected hand), contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, penile swelling, penile pain, pruritus, lymphadenopathy, axillary mass, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, blood blister, injection site hematoma, ecchymosis, injection site swelling, penile ""popping"" sounds or sensations, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain, penile blister, death"
43,XIAFLEX,boxed warnings,"corporal rupture, penile fracture, serious penile injury, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound, severe penile hematoma"
44,XIAFLEX,warnings and precautions,"tendon rupture, serious injury to the injected finger/hand, permanent injury, ligament damage, skin laceration, corporal rupture (penile fracture), serious injury to the penis, hypersensitivity reactions, anaphylaxis, abnormal coagulation, flexor tendon ruptures, damage to collagen-containing structures, pulley rupture, complex regional pain syndrome (CRPS), sensory abnormality of the hand, penile ecchymoses, penile hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, severe penile hematoma, allergic reactions, pruritus, IgE-anti-drug antibodies, ecchymosis/contusion, injection site hemorrhage, bleeding, coagulation disorders."
45,XEOMIN,adverse reactions,"hypersensitivity, dysphagia, breathing difficulties, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, facial paresis, injection site hematoma, eyelid edema, brow ptosis, sensation of pressure, blepharospasm, eye disorder, facial pain, injection site swelling, muscle disorder, elevation of eyebrow, eye swelling, nausea, flu-like symptoms, injection site reaction, allergic dermatitis, localized allergic reactions, swelling, erythema, pruritus, rash, herpes zoster, muscle spasm, dysarthria, myalgia, hypersensitivity <negated>, death"
46,XEOMIN,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
47,XEOMIN,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, compromised respiratory function, dysphagia, neuromuscular disorders, cervical dystonia, smaller neck muscle mass, sternocleidomastoid muscles, corneal exposure, corneal ulceration, reduced blinking, ulceration, perforation, diplopia <negated>, ptosis, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death, hypersensitivity reactions, anaphylaxis, serum sickness, urticaria, soft tissue edema, dyspnea, severe dysphagia, aspiration, respiratory failure, peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, neuromuscular junctional disorders, myasthenia gravis, Lambert-Eaton syndrome, ectropion, VII nerve disorders, narrow angle glaucoma <negated>, ecchymosis, viral diseases <negated>, Creutzfeldt-Jakob disease (CJD) <negated>"
48,GILOTRIF,adverse reactions,"Diarrhea, Bullous Skin Disorders, Exfoliative Skin Disorders, Interstitial Lung Disease, Hepatic Toxicity, Keratitis, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, pulmonary toxicity/ILD-like adverse reactions, sepsis, pneumonia, ventricular dysfunction, Gastrointestinal disorders, Skin and subcutaneous tissue disorders, Infections and infestations, Metabolism and nutrition disorders, Respiratory, thoracic and mediastinal disorders, Investigations, General disorders and administration site conditions, Eye disorders, Laboratory Abnormalities, Alanine aminotransferase increased, Hypokalemia, Aspartate aminotransferase increased, Pancreatitis, death"
49,GILOTRIF,warnings and precautions,"diarrhea, dehydration, renal failure, severe diarrhea <negated>, prolonged diarrhea <negated>, bullous skin disorders, exfoliative skin disorders, blistering lesions, exfoliating lesions, life-threatening cutaneous reactions <negated>, severe cutaneous reactions <negated>, prolonged cutaneous reactions <negated>, interstitial lung disease (ILD), lung infiltration, pneumonitis, acute respiratory distress syndrome, alveolitis allergic, fatal ILD, hepatic toxicity, fatal hepatic impairment, liver test abnormalities, severe hepatic impairment <negated>, keratitis, eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, ulcerative keratitis, severe dry eye, embryofetal toxicity, fetal harm, abortions, death"
50,TREANDA,adverse reactions,"myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, other malignancies, extravasation injury, pyrexia, nausea, vomiting, fatigue, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, asthenia, malaise, weakness, dry mouth, somnolence, mucosal inflammation, hypertension <negated>, hypertensive crisis, hypersensitivity, nasopharyngitis, infection, herpes simplex, hyperuricemia, pruritus, hemoglobin decreased, platelets decreased, leukocytes decreased, lymphocytes decreased, neutrophils decreased, bilirubin increased, AST increased <negated>, ALT increased <negated>, creatinine levels changes, tachycardia, constipation, stomatitis, abdominal pain, dyspepsia, gastroesophageal reflux disease, abdominal pain upper, abdominal distension, chills, edema peripheral, chest pain, infusion site pain, pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, pneumonia, febrile neutropenia, oral candidiasis, weight decreased, anorexia, dehydration, decreased appetite, hypokalemia, back pain, arthralgia, pain in extremity, bone pain, headache, dizziness, dysgeusia, insomnia, anxiety, depression, cough, dyspnea, pharyngolaryngeal pain, wheezing, nasal congestion, dry skin, night sweats, hyperhidrosis, hypotension, acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, dysgeusia/taste disorder, atypical pneumonia, sepsis, erythema, dermatitis, skin necrosis, anaphylaxis, injection or infusion site reactions, phlebitis, pruritus, irritation, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), death"
51,TREANDA,warnings and precautions,"myelosuppression, death, infections, fever, anaphylaxis, infusion reactions, tumor lysis syndrome, acute renal failure, skin reactions, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), pre-malignant diseases, malignant diseases, myelodysplastic syndrome, myeloproliferative disorders, acute myeloid leukemia, bronchial carcinoma, extravasation injury, erythema, swelling, pain, infection, necrosis, embryo-fetal toxicity, resorptions, skeletal malformations, visceral malformations, decreased fetal body weights"
52,CHOLINE,adverse reactions,mild injection site reaction
53,CHOLINE,warnings and precautions,"Imaging errors, allergic reactions, radiation risk, poor imaging performance, false positive results, false negative results, tissue inflammation, prostatic hyperplasia, cancer risk, death"
54,ERWINAZE,adverse reactions,"Hypersensitivity reactions, Pancreatitis, Glucose intolerance, Thrombosis, Hemorrhage, Systemic hypersensitivity, Hyperglycemia, Transaminases abnormal, Fever, Local reactions, Vomiting, Nausea, Hyperbilirubinemia, Abdominal pain/discomfort, Diarrhea, Allergic reactions, Coagulopathy, Hyperlipidemia, Ketoacidosis, CNS events (including cerebral venous thrombosis), Hepatobiliary disorders, Pancreatic disorders, Anti-drug antibodies (ADA) <negated>, Neutralizing antibodies <negated>."
55,ERWINAZE,warnings and precautions,"serious hypersensitivity reactions, anaphylaxis, severe pancreatitis, hemorrhagic pancreatitis, glucose intolerance, hyperglycemia, thrombosis, hemorrhage, sagittal sinus thrombosis, pulmonary embolism, decreased fibrinogen, decreased protein C activity, decreased protein S activity, decreased anti-thrombin III"
56,TRULICITY,adverse reactions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, Nausea, Diarrhea, Vomiting, Abdominal pain, Decreased appetite, Dyspepsia, Fatigue, Constipation, Flatulence, Abdominal distension, Gastroesophageal reflux disease, Eructation, Documented symptomatic hypoglycemia, Severe hypoglycemia, Heart Rate Increase, Tachycardia, Sinus tachycardia, Immunogenicity, Anti-drug antibodies, Dulaglutide-neutralizing antibodies, Antibodies against native GLP-1, Systemic hypersensitivity, Severe urticaria, Systemic rash, Facial edema, Lip swelling, Injection-site reactions, Injection-site rash, Erythema, PR Interval Prolongation, First Degree Atrioventricular Block, Amylase increase, Lipase increase"
57,TRULICITY,boxed warnings,"thyroid C-cell tumors, adenomas, carcinomas, medullary thyroid carcinoma (MTC), mass in the neck <negated>, dysphagia <negated>, dyspnea <negated>, persistent hoarseness <negated>, death"
58,TRULICITY,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Severe Gastrointestinal Disease, death"
59,ADREVIEW,adverse reactions,"hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising"
60,ADREVIEW,warnings and precautions,"hypersensitivity reactions, anaphylactic treatment measures, serious reactions, severe renal impairment, increased radiation exposure, decreased quality of AdreView images, iodine 123 accumulation, thyroid neoplasia, hypertension, transient episode of hypertension, Gasping Syndrome <negated>, hypotension <negated>, metabolic acidosis <negated>, kernicterus <negated>, death"
61,DOTAREM,adverse reactions,"NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site inflammation, injection site extravasation, injection site pruritus, injection site warmth, bradycardia, tachycardia, arrhythmia, anaphylactoid reactions, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis, death <negated> NSF alone with DOTAREM."
62,DOTAREM,boxed warnings,"NEPHROGENIC SYSTEMIC FIBROSIS (NSF), fatal or debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, Chronic, severe kidney disease, Acute kidney injury, death"
63,DOTAREM,warnings and precautions,"Nephrogenic Systemic Fibrosis, Anaphylactoid reactions, Anaphylactic reactions, Cardiovascular manifestations, Respiratory manifestations, Cutaneous manifestations, Death, Acute kidney injury, Chronic severe kidney disease, Chronic moderate kidney disease, Chronic mild kidney disease, Fibrosis affecting the skin, Fibrosis affecting the muscle, Fibrosis affecting internal organs, Surgery-related kidney toxicity, Severe infection-related kidney toxicity, Injury-related kidney toxicity, Drug-induced kidney toxicity, Circulatory collapse, Hypersensitivity reactions, Extravasation, Tissue irritation"
64,PRADAXA,adverse reactions,"bleeding, gastritis-like symptoms, gastrointestinal hemorrhage, dyspepsia, nausea, upper abdominal pain, diarrhea, major bleeding, intracranial hemorrhage, hemorrhagic stroke, subarachnoid bleed, subdural bleed, gastrointestinal bleeds, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, symptomatic bleeding, intraocular bleed, intraspinal bleed, intramuscular bleed with compartment syndrome, retroperitoneal bleeding, intra-articular bleeding, pericardial bleeding, fatal bleeding <death>, non-intracranial fatal bleed <death>, abdominal pain upper, abdominal discomfort, epigastric discomfort, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, clinical myocardial infarction, angioedema, thrombocytopenia, esophageal ulcer"
65,PRADAXA,boxed warnings,"thrombotic events, spinal/epidural hematoma, paralysis, neurological impairment, long-term paralysis, permanent paralysis"
66,PRADAXA,warnings and precautions,"serious bleeding, fatal bleeding, death, thrombotic events <negated>, pathological bleeding, blood loss, hypotension, renal impairment, epidural hematoma, spinal hematoma, paralysis, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, major bleeding, post-operative pericardial effusions, neurological impairment, back pain, sensory deficits, motor deficits, numbness, tingling, weakness in lower limbs, bowel dysfunction, bladder dysfunction, spinal cord decompression <negated>, hemodynamic compromise"
67,ELIQUIS,adverse reactions,"thrombotic events, bleeding, Spinal/epidural anesthesia or puncture, hemorrhagic stroke, intracranial bleed, gastrointestinal (GI) bleed, fatal bleeding, intracranial, non-intracranial, hypersensitivity reactions, skin rash, anaphylactic reactions, allergic edema, syncope, nausea, anemia, postoperative anemia, hemorrhagic anemia, contusion, hemorrhage, hematoma, vaginal hemorrhage, urethral hemorrhage, postprocedural hemorrhage, wound hemorrhage, vessel puncture site hematoma, catheter site hemorrhage, transaminases increased, alanine aminotransferase increased, alanine aminotransferase abnormal, aspartate aminotransferase increased, gamma-glutamyltransferase increased, thrombocytopenia, platelet count decreases, hypotension, procedural hypotension, epistaxis, gastrointestinal hemorrhage, hematemesis, melena, hematochezia, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, hematuria, wound secretion, incision-site hemorrhage, incision-site hematoma, operative hemorrhage, gingival bleeding, hemoptysis, muscle hemorrhage, ocular hemorrhage, conjunctival hemorrhage, rectal hemorrhage, menorrhagia, menometrorrhagia, genital hemorrhage, hemorrhagic anemia, hemorrhoidal hemorrhage, traumatic hematoma, periorbital hematoma, muscle hemorrhage, vaginal hemorrhage, metrorrhagia, hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, occult blood, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma, death"
68,ELIQUIS,boxed warnings,"thrombotic events, SPINAL/EPIDURAL HEMATOMA, long-term or permanent paralysis, death"
69,ELIQUIS,warnings and precautions,"serious bleeding, potentially fatal bleeding, death, increased risk of thrombotic events, stroke, bleeding, pathological bleeding, active pathological hemorrhage, epidural hematoma, spinal hematoma, long-term paralysis, permanent paralysis, neurological impairment, numbness, weakness of the legs, bowel dysfunction, bladder dysfunction, acute PE in hemodynamically unstable patients, thrombolysis, pulmonary embolectomy, <negated> use in patients with prosthetic heart valves"
70,ZERBAXA,adverse reactions,"Hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, cardiac disorders, tachycardia, angina pectoris, gastrointestinal disorders, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, general disorders and administration site conditions, infusion site reactions, infections and infestations, candidiasis, oropharyngeal, fungal urinary tract infection, investigations, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, metabolism and nutrition disorders, hyperglycemia, hypomagnesemia, hypophosphatemia, nervous system disorders, ischemic stroke, respiratory, thoracic and mediastinal disorders, dyspnea, skin and subcutaneous tissue disorders, urticaria, vascular disorders, venous thrombosis, death"
71,ZERBAXA,warnings and precautions,"decreased efficacy, serious hypersensitivity reactions, anaphylactic reactions, Clostridium difficile-associated diarrhea (CDAD), mild diarrhea, fatal colitis, death, drug-resistant bacteria"
72,FERRIPROX,adverse reactions,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension, death"
73,FERRIPROX,boxed warnings,"agranulocytosis, neutropenia, serious infections, death"
74,FERRIPROX,warnings and precautions,"infection, fetal harm, agranulocytosis, neutropenia, death, embryofetal death, malformations, increased ALT values, increased AST values, decreased plasma zinc concentrations"
75,DALVANCE,adverse reactions,"nausea, vomiting, diarrhea, headache, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, ALT elevations"
76,DALVANCE,warnings and precautions,"serious hypersensitivity, anaphylactic reactions, skin reactions, rapid intravenous infusion reactions, ALT elevations, Clostridium difficile-associated diarrhea (CDAD), flushing of the upper body, urticaria, pruritus, rash, liver test abnormalities, ALT elevation, AST elevation, bilirubin elevation, mild diarrhea, fatal colitis <death>, hypertoxin-producing strains morbidity, hypertoxin-producing strains mortality, drug-resistant bacteria"
77,ARCAPTA,adverse reactions,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD <negated>, dyspnea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia/heart rate increase/palpitations, pruritus/rash, dizziness, death"
78,ARCAPTA,boxed warnings,"asthma-related death, death"
79,ARCAPTA,warnings and precautions,"clinically significant cardiovascular effects, death, Immediate hypersensitivity reactions, Life-threatening paradoxical bronchospasm, serious asthma-related events, asthma-related death, deterioration of disease, acute episodes of bronchospasm, paradoxical bronchospasm, increases in pulse rate, systolic or diastolic blood pressure, ECG changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, significant hypokalemia, increases in plasma glucose"
80,CERDELGA,adverse reactions,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash"
81,CERDELGA,warnings and precautions,"ECG Changes, Cardiac Arrhythmias, prolongation of the PR interval, QTc interval prolongation, QRS interval prolongation, congestive heart failure <negated>, acute myocardial infarction <negated>, bradycardia <negated>, heart block <negated>, ventricular arrhythmia <negated>, long QT syndrome, death"
82,GADAVIST,adverse reactions,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, headache, nausea, dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash, Pruritus, Erythema, Hypersensitivity/Anaphylactoid, Dyspnea, Paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, Cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, death"
83,GADAVIST,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal or debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, Chronic severe kidney disease, Acute kidney injury, death"
84,GADAVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, Anaphylactic reactions, Hypersensitivity reactions, Cardiovascular manifestations, Respiratory manifestations, Cutaneous manifestations, Death, Acute kidney injury, Dialysis <negated>, Extravasation, Injection site reactions, Overestimation of malignant disease."
85,ZYKADIA,adverse reactions,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, convulsion, pneumonia, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, neuropathy, vision disorder, prolonged QT interval, hemoglobin decreased, alanine transaminase (ALT) increased, aspartate transaminase (AST) increased, creatinine increased, glucose increased, phosphate decreased, lipase increased, bilirubin (total) increased, death"
86,ZYKADIA,warnings and precautions,"diarrhea, nausea, vomiting, abdominal pain, hepatotoxicity, Interstitial Lung Disease (ILD), pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, Embryofetal Toxicity, death"
87,XALKORI,adverse reactions,"hepatotoxicity, interstitial lung disease, pneumonitis, QT interval prolongation, bradycardia, severe visual loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, death, abdominal pain, pyrexia, weight increased, pain in extremity, muscle spasm, dizziness, headache, fatigue, neuropathy, gait disturbance, hypoaesthesia, muscular weakness, neuralgia, neuropathy peripheral, paraesthesia, peripheral sensory neuropathy, polyneuropathy, sensory disturbance, rash, renal cyst, syncope, neutropenia, lymphopenia, ALT elevation, AST elevation, hypophosphatemia, dysphagia, dyspepsia, acute respiratory distress syndrome, arrhythmia, pneumonia, respiratory failure, sepsis, hypokalemia, hepatic failure, photopsia, blurred vision, vitreous floaters, visual impairment, dysesthesia, burning sensation in skin"
88,XALKORI,warnings and precautions,"hepatotoxicity, fatal hepatotoxicity, death, Interstitial Lung Disease (ILD), Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, Embryofetal Toxicity, elevated transaminases, severe visual loss, vision loss, optic atrophy, optic nerve disorder, embryotoxicity, fetotoxicity"
89,BEPREVE,adverse reactions,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, swelling of tongue, swelling of throat"
90,BEPREVE,warnings and precautions,"contact lens-related irritation <negated>, contamination, eye is red <negated>"
91,EDARBI,adverse reactions,"diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, rash, pruritus, angioedema"
92,EDARBI,boxed warnings,"fetal toxicity, injury, death"
93,EDARBI,warnings and precautions,"fetal toxicity, fetal renal function reduction, fetal and neonatal morbidity, death, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, hypotension, renal failure, symptomatic hypotension, oliguria, progressive azotemia, acute renal failure, serum creatinine increase, blood urea nitrogen increase"
94,POTIGA,adverse reactions,"Retinal abnormalities, potential vision loss, Urinary retention, Skin discoloration, Neuropsychiatric symptoms, Dizziness, somnolence, QT interval effect, Suicidal behavior, ideation, Withdrawal seizures, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, Nausea, Constipation, Dyspepsia, Influenza, Weight increased, Paresthesia, Amnesia, Dysphasia, Confusional state, Anxiety, Disorientation, Psychotic disorder, Dysuria, Urinary hesitation, Hematuria, Chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, urinary retention <negated>, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy, death"
95,POTIGA,boxed warnings,"retinal abnormalities, potential vision loss, damage to the photoreceptors, vision loss, abnormal visual acuity, decreased visual acuity, retinal pigmentary abnormalities, vision changes"
96,POTIGA,warnings and precautions,"urinary retention, skin discoloration, neuropsychiatric symptoms, confusional state, psychotic symptoms, hallucinations, dizziness, somnolence, QT prolongation, suicidal thoughts, suicidal behaviors, retinal abnormalities, potential vision loss, vision loss, retinal pigmentary abnormalities, funduscopic abnormalities, perivascular pigmentation, retinal pigment epithelium clumping, abnormal visual acuity, retinal dystrophy, electroretinogram abnormalities, electrooculogram abnormalities, abnormal fluorescein angiography, diminished sensitivity on visual field testing, hydronephrosis, renal function impairment<negated>, urinary hesitation<negated>, dysuria<negated>, blue skin discoloration, grey-blue skin discoloration, brown skin discoloration, nail discoloration, lip discoloration, mucous membrane discoloration, palate discoloration, scleral discoloration, conjunctiva discoloration, psychosis, visual hallucinations, auditory hallucinations, mixed hallucinations, withdrawal seizures, death"
97,TUDORZA,adverse reactions,"Paradoxical bronchospasm, Worsening of narrow-angle glaucoma, Worsening of urinary retention, Immediate Hypersensitivity Reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, death, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching"
98,TUDORZA,warnings and precautions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, angioedema, anaphylaxis, bronchospasm, urticaria, rash, itching, eye pain, discomfort, blurred vision, visual halos, colored images, red eyes, conjunctival congestion, corneal edema, difficulty passing urine, painful urination, swelling of the lips, tongue, throat, death"
99,PROMACTA,adverse reactions,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, abdominal pain, toothache, vitamin D deficiency, dyspnea, pain in extremity, dizziness, febrile neutropenia, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea, Thrombotic microangiopathy with acute renal failure."
100,PROMACTA,boxed warnings,hepatic decompensation
101,PROMACTA,warnings and precautions,"Hepatotoxicity, Portal vein thrombosis, Hepatic decompensation, Ascites, Encephalopathy, Liver enzyme elevations, Indirect hyperbilirubinemia, Increased direct bilirubin, Clinical symptoms of liver injury, Thrombotic event, Venous and arterial events, Thrombotic/thromboembolic complications, Abdominal pain, Nausea, Vomiting, Diarrhea, Cataracts"
102,INLYTA,adverse reactions,"hypertension, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation, fistula formation, thyroid dysfunction, wound healing complications, RPLS, proteinuria, elevation of liver enzymes, hepatic impairment, fetal development, diarrhea, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hemoglobin decreased, lymphocytes decreased, platelets decreased, white blood cells decreased, creatinine increased, bicarbonate decreased, hypocalcemia, ALP increased, hyperglycemia, amylase increased, ALT increased, AST increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin increased <negated>, hypercalcemia <negated>"
103,INLYTA,warnings and precautions,"hypertension, hypertensive crisis, arterial thrombotic events, venous thrombotic events, death, hemorrhagic events, cardiac failure, gastrointestinal perforation, fistula, hypothyroidism, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), proteinuria, liver enzyme elevation, fetal harm, hyperthyroidism, wound healing complications, elevation of liver enzymes, hepatic impairment"
104,NORTHERA,adverse reactions,"Supine Hypertension, Hyperpyrexia, Confusion, exacerbate existing ischemic heart disease <negated>, arrhythmias <negated>, congestive heart failure <negated>, Headache, dizziness, nausea, hypertension, fatigue, falls, urinary tract infections, syncope"
105,NORTHERA,boxed warnings,supine hypertension
106,NORTHERA,warnings and precautions,"supine hypertension, cardiovascular risk, hyperpyrexia, confusion, exacerbate symptoms, ischemic heart disease, arrhythmias, congestive heart failure, allergic reactions, neuroleptic malignant syndrome (NMS), fever, hyperthermia, muscle rigidity, involuntary movements, altered consciousness, mental status changes, death, allergic-type reactions, bronchial asthma, aspirin hypersensitivity"
107,JARDIANCE,adverse reactions,"Hypotension, Impairment in Renal Function, Hypoglycemia, Genital Mycotic Infections, Urinary Tract Infections, Increased Low-Density Lipoprotein Cholesterol (LDL-C), Upper respiratory tract infection, Increased urination, Dyslipidemia, Arthralgia, Nausea, Thirst (including polydipsia), Volume Depletion, Increased Urination, Impairment in Renal Function, Hypoglycemia, Genital Mycotic Infections, Phimosis, Urinary Tract Infections, Increase in Low-Density Lipoprotein Cholesterol (LDL-C), Increase in Hematocrit"
108,JARDIANCE,warnings and precautions,"hypotension, renal function impairment, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C, <negated> macrovascular risk reduction"
109,FANAPT,adverse reactions,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, akathisia, bradykinesia, dyskinesia, dystonia, parkinsonism, palpitations, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation"
110,FANAPT,boxed warnings,"increased mortality, death, cardiovascular events, heart failure, sudden death, infectious events, pneumonia"
111,FANAPT,warnings and precautions,"death, cerebrovascular-related adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, Tardive dyskinesia, Hyperglycemia, diabetes mellitus, polydipsia, polyuria, polyphagia, weakness, Dyslipidemia, Weight Gain, Seizures, Orthostatic hypotension, dizziness, tachycardia, syncope, Leukopenia, Neutropenia, Agranulocytosis, Suicide, Priapism, cognitive impairment, motor impairment, somnolence, sedation"
112,TANZEUM,adverse reactions,"Risk of Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, upper respiratory tract infection, diarrhea, nausea, injection site reaction, cough, back pain, arthralgia, sinusitis, influenza, vomiting, gastroesophageal reflux disease, dyspepsia, constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, pneumonia, atrial fibrillation, atrial flutter, appendicitis, liver enzyme abnormalities, alanine aminotransferase (ALT) increase, Gamma Glutamyltransferase (GGT) Increase, heart rate increase"
113,TANZEUM,boxed warnings,"thyroid C-cell tumors, medullary thyroid carcinoma (MTC), mass in the neck <negated>, dysphagia <negated>, dyspnea <negated>, persistent hoarseness <negated>"
114,TANZEUM,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Acute Pancreatitis, Serious Hypersensitivity Reaction, Pruritus, Rash, Dyspnea, Acute Renal Failure, Worsening of Chronic Renal Failure, Nausea, Vomiting, Diarrhea, Dehydration, Elevated Serum Calcitonin <negated>, Macrovascular Risk Reduction <negated>"
115,EYLEA,adverse reactions,"Endophthalmitis, retinal detachments, Increased intraocular pressure, Thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, intraocular pressure increased, vitreous detachment, Ocular hyperemia, Corneal epithelium defect, Detachment of the retinal pigment epithelium, Injection site pain, Foreign body sensation in eyes, Lacrimation increased, Vision blurred, Intraocular inflammation, Retinal pigment epithelium tear, Injection site hemorrhage, Eyelid edema, Corneal edema, hypersensitivity, retinal detachment, retinal tear, endophthalmitis, hypersensitivity, retinal detachment, retinal tear, corneal edema, injection site hemorrhage"
116,EYLEA,warnings and precautions,"endophthalmitis, retinal detachments, increases in intraocular pressure, arterial thromboembolic events, nonfatal stroke, nonfatal myocardial infarction, vascular death, death"
117,JEVTANA,adverse reactions,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Embryo-Fetal Toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, death, infections, ventricular fibrillation, cerebral hemorrhage, febrile neutropenia, arrhythmia, dyspepsia, peripheral edema, mucosal inflammation, pain, urinary tract infection, weight decreased, dehydration, muscle spasms, dizziness, headache, dysuria, hypotension, sepsis, septic shock, increased AST, increased ALT, increased bilirubin, gastritis, intestinal obstruction."
118,JEVTANA,boxed warnings,"neutropenia, neutropenic deaths <death>, hypersensitivity, generalized rash/erythema, hypotension, bronchospasm"
119,JEVTANA,warnings and precautions,"bone marrow suppression, neutropenia, febrile neutropenia, neutropenic infections, death, hypersensitivity reactions, severe hypersensitivity reactions, gastrointestinal disorders, nausea, vomiting, diarrhea, gastrointestinal hemorrhage, gastrointestinal perforation, neutropenic enterocolitis, renal failure, anemia, thrombocytopenia, pancytopenia, sepsis, septic shock, electrolyte imbalance, GI hemorrhage, GI perforation, ileus, enterocolitis, abdominal pain, fever, persistent constipation, obstructive uropathy, embryo-fetal toxicity, embryotoxic, fetotoxic, abortifacient"
120,YERVOY,adverse reactions,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, enterocolitis <negated>, hepatitis <negated>, dermatitis <negated>, neuropathy <negated>, endocrinopathy <negated>, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), death"
121,YERVOY,boxed warnings,"enterocolitis, hepatitis, dermatitis, toxic epidermal necrolysis, neuropathy, endocrinopathy, death"
122,YERVOY,warnings and precautions,"severe immune-mediated reactions, fatal immune-mediated reactions, immune-mediated hepatitis, immune-mediated endocrinopathies, immune-mediated enterocolitis, severe enterocolitis, life-threatening enterocolitis, fatal enterocolitis, moderate enterocolitis, intestinal perforation, complications <negated>, severe enterocolitis, hospitalization for severe enterocolitis, immune-mediated dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, rash complicated by full thickness dermal ulceration, necrotic dermatitis, bullous dermatitis, hemorrhagic dermatitis, severe dermatitis, moderate dermatitis, immune-mediated neuropathies, fatal Guillain-Barre syndrome, severe peripheral motor neuropathy, myasthenia gravis, Guillain-Barre syndrome, severe neuropathy, moderate neuropathy, severe to life-threatening immune-mediated endocrinopathies, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, hyperthyroidism, Cushing's syndrome, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis, hepatotoxicity, fatal hepatic failure, hospitalization <negated>, moderate hepatotoxicity, immune-mediated hepatitis, increases in transaminases, death"
123,FARXIGA,adverse reactions,"Hypotension, Impairment in Renal Function, Hypoglycemia, Genital Mycotic Infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, Female genital mycotic infections, Nasopharyngitis, Urinary tract infections, Back pain, Increased urination, Male genital mycotic infections, Nausea, Influenza, Dyslipidemia, Constipation, Discomfort with urination, Pain in extremity, Volume Depletion, Dehydration, Hypovolemia, Orthostatic hypotension, Renal failure, Blood creatinine increase, Bone fractures, Hypersensitivity Reactions, Angioedema, Urticaria, Anaphylactic reactions, Severe cutaneous adverse reactions, Increase in Hematocrit, Increase in Serum Inorganic Phosphorus, Hyperphosphatemia"
124,FARXIGA,warnings and precautions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increased LDL-C, bladder cancer, death"
125,PICATO,adverse reactions,"local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn"
126,PICATO,warnings and precautions,"severe eye pain, chemical conjunctivitis, corneal burn, eyelid edema, eyelid ptosis, periorbital edema, vesiculation/pustulation, erosion/ulceration, erythema, crusting, swelling, anaphylaxis, allergic contact dermatitis"
127,PRISTIQ,adverse reactions,"Hypersensitivity, Suicidal Thoughts and Behaviors in Adolescents and Young Adults, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, Blood pressure increased, Dry mouth, Vomiting, Fatigue, Chills, Feeling jittery, Decreased appetite, Tremor, Disturbance in attention, Insomnia, Nervousness, Abnormal dreams, Urinary hesitation, Yawning, Vision blurred, Mydriasis, Vertigo, Tinnitus, Dysgeusia, Hot flush, Anorgasmia, Libido decreased, Orgasm abnormal, Ejaculation delayed, Erectile dysfunction, Ejaculation disorder, Ejaculation failure, Sexual dysfunction, Tachycardia, Asthenia, Weight increased, liver function test abnormal, blood prolactin increased, Musculoskeletal stiffness, Syncope, convulsion, dystonia, Depersonalization, bruxism, Urinary retention, Rash, alopecia, photosensitivity reaction, angioedema, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, Proteinuria, Supine systolic bp increase, Supine diastolic bp increase, Supine pulse increase, Weight loss, Sustained hypertension, Orthostatic hypotension, Stevens-Johnson syndrome, death (due to mention of fatal events such as myocardial infarction and Stevens-Johnson syndrome)."
128,PRISTIQ,boxed warnings,"suicidal thoughts, suicidal behaviors, worsening of depression <negated>, emergence of suicidal thoughts, emergence of suicidal behaviors, death"
129,PRISTIQ,warnings and precautions,"Clinical Worsening, Suicide Risk, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, Suicidal Thoughts and Behaviors, Suicidality, Anxiety, Agitation, Panic Attacks, Insomnia, Irritability, Hostility, Aggressiveness, Impulsivity, Akathisia, Psychomotor Restlessness, Hypomania, Mania, Mental Status Changes, Autonomic Instability, Tachycardia, Labile Blood Pressure, Dizziness, Diaphoresis, Flushing, Hyperthermia, Neuromuscular Symptoms, Tremor, Rigidity, Myoclonus, Hyperreflexia, Incoordination, Gastrointestinal Symptoms, Nausea, Vomiting, Diarrhea, Ecchymosis, Hematoma, Epistaxis, Petechiae, Hemorrhages, Dysphoric Mood, Sensory Disturbances, Paresthesia, Electric Shock Sensations, Confusion, Headache, Lethargy, Emotional Lability, Tinnitus, Seizures, Progressive Dyspnea, Cough, Chest Discomfort, death (due to mention of suicides in adult studies)."
130,STRIBILD,adverse reactions,"Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, nausea, diarrhea, Ocular icterus, Flatulence, Fatigue, Jaundice, Somnolence, Headache, Dizziness, Insomnia, Abnormal dreams, Rash, suicidal ideation <negated>, suicide attempt <negated>, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, Skin discoloration, Proteinuria, allergic reaction, angioedema, lactic acidosis, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, hepatic steatosis, hepatitis, increased liver enzymes, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, polyuria, asthenia, death"
131,STRIBILD,boxed warnings,"lactic acidosis, severe hepatomegaly with steatosis, death, severe acute exacerbation of hepatitis B"
132,STRIBILD,warnings and precautions,"acute renal failure, Fanconi syndrome, renal impairment, bone mineral density (BMD) decrease, redistribution/accumulation of body fat, immune reconstitution syndrome, lactic acidosis, severe hepatomegaly with steatosis, death, severe acute exacerbations of hepatitis B, liver decompensation, liver failure, proximal renal tubulopathy, bone pain, pain in extremities, fractures, muscular pain, weakness, osteomalacia, arthralgias, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", inflammatory response to indolent or residual opportunistic infections, autoimmune disorders (such as Graves' disease, polymyositis, Guillain-Barre syndrome)"
133,NULOJIX,adverse reactions,"PTLD, CNS PTLD, malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, non-melanoma skin cancer, bacterial infections, mycobacterial infections, viral infections, fungal infections, tuberculosis, herpes infections, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, infusion reactions, hypotension, proteinuria, immunogenicity, new-onset diabetes after transplantation (NODAT), dyslipidemia, hematuria, dysuria, renal tubular necrosis, hypotension, dyspnea, blood creatinine increased, arthralgia, back pain, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation, death (due to fatal cases of PML)."
134,NULOJIX,boxed warnings,"post-transplant lymphoproliferative disorder, central nervous system involvement, malignancies, serious infections, increased susceptibility to infection, graft loss, death"
135,NULOJIX,warnings and precautions,"Post-Transplant Lymphoproliferative Disorder (PTLD), Other malignancies, Progressive Multifocal Leukoencephalopathy (PML), serious infections, bacterial infections, viral infections, fungal infections, protozoal infections, opportunistic infections, tuberculosis, Polyoma virus-associated nephropathy (PVAN), kidney graft loss, Liver transplant <negated>, Acute Rejection, Graft Loss, Immunizations <negated>, death"
136,LUMIZYME,adverse reactions,"anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, rash erythematous, rash macular, maculo-papular rash, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, angioedema, throat tightness, supraventricular tachycardia, local swelling, diarrhea, pruritus, papular rash, edema peripheral, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions, death"
137,LUMIZYME,boxed warnings,"anaphylaxis, hypersensitivity reactions, immune-mediated reactions, cardiorespiratory failure, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, proteinuria, nephrotic syndrome, necrotizing skin lesions, fluid overload, acute exacerbation of cardiac compromise, acute exacerbation of respiratory compromise, death"
138,LUMIZYME,warnings and precautions,"anaphylaxis, hypersensitivity reactions, anaphylactic shock, cardiac arrest, respiratory arrest, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, chest discomfort, chest pain, wheezing, tachypnea, cyanosis, decreased oxygen saturation, convulsions, pruritus, rash, hyperhidrosis, nausea, dizziness, hypertension, increased blood pressure, flushing, feeling hot, erythema, pyrexia, pallor, peripheral coldness, restlessness, nervousness, headache, back pain, paresthesia, immune-mediated cutaneous reactions, necrotizing skin lesions, systemic immune-mediated reactions, type III immune-mediated reactions, inflammatory arthropathy, pyrexia, elevated erythrocyte sedimentation rate, nephrotic syndrome, membranous glomerulonephritis, immune complex deposition, acute cardiorespiratory failure, cardiac hypertrophy, fluid overload, ventricular arrhythmias, bradycardia, cardiac arrest, death, cardiac resuscitation, defibrillation, antibody development, reduced clinical efficacy, loss of motor function, ventilator dependence, death."
139,EOVIST,adverse reactions,"Nephrogenic systemic fibrosis (NSF), Hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions (pain, burning, coldness, extravasation, irritation), dysgeusia, paresthesia, flushing, parosmia, pruritus (generalized, eye), rash, respiratory disorders (dyspnea, respiratory distress), fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness"
140,EOVIST,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal or debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, chronic severe kidney disease, acute kidney injury, death"
141,EOVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, anaphylactoid reactions, hypersensitivity reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, severe reactions, shock, acute kidney injury, NSF, fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, death (due to fatal or debilitating fibrosis), surgery-related kidney toxicity, severe infection-related kidney toxicity, injury-related kidney toxicity, drug-induced kidney toxicity, chronic renal impairment, dialysis, extravasation, local tissue reactions, myocyte necrosis, inflammation, falsely high serum iron values, falsely low serum iron values, reduced hepatic contrast, elevated serum ferritin levels, reduced hepatic contrast due to high serum bilirubin."
142,BELEODAQ,adverse reactions,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, Nausea, Fatigue, Pyrexia, Anemia, Vomiting, Constipation, Diarrhea, Dyspnea, Rash, Peripheral Edema, Cough, Thrombocytopenia, Pruritus, Chills, Increased Blood Lactate Dehydrogenase, Decreased Appetite, Headache, Infusion Site Pain, Hypokalemia, Prolonged QT, Abdominal pain, Hypotension, Phlebitis, Dizziness, Pneumonia, Increased creatinine, Multi-organ failure, Death, Febrile neutropenia"
143,BELEODAQ,warnings and precautions,"thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, infection, serious infections, fatal infections <death>, pneumonia, sepsis <death>, hepatotoxicity, liver function test abnormalities, tumor lysis syndrome, nausea, vomiting, diarrhea, embryo-fetal toxicity, fetal harm, teratogenicity, embryo-fetal lethality, genotoxicity"
144,VICTRELIS,adverse reactions,"fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia <negated>, hypersensitivity <negated>, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma"
145,VICTRELIS,warnings and precautions,"Embryofetal Toxicity, birth defects, fetal death, Anemia, decrease in hemoglobin concentrations, Neutropenia, worsening of neutropenia, Hypersensitivity, acute hypersensitivity reactions, urticaria, angioedema, pancytopenia, thromboembolic events, pulmonary embolism, acute myocardial infarction, cerebrovascular accident, deep vein thrombosis, dyspnea, exertional dyspnea, dizziness, syncope, severe or life-threatening infections, severe or life-threatening neutropenia, death"
146,VIMIZIM,adverse reactions,"Anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, anti-drug antibodies, <negated>new adverse reactions, <negated>reductions in treatment effect, <negated>association between antibody titers and occurrence of anaphylaxis or other hypersensitivity reactions, <negated>association between neutralizing antibody titer and treatment effect."
147,VIMIZIM,boxed warnings,"anaphylaxis, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, hypersensitivity reactions, acute respiratory illness, serious acute exacerbation, respiratory compromise, death"
148,VIMIZIM,warnings and precautions,"anaphylaxis, hypersensitivity reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, peripheral edema, acute respiratory complications, sleep apnea, spinal or cervical cord compression, back pain, paralysis, urinary incontinence, fecal incontinence, death"
149,SIRTURO,adverse reactions,"Increased mortality, death, QT Prolongation, Hepatotoxicity, Drug Interactions, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, Transaminases Increased, rash, Blood Amylase Increased"
150,SIRTURO,boxed warnings,"Increased Mortality, QT Prolongation, death"
151,SIRTURO,warnings and precautions,"QT prolongation, ventricular arrhythmia, QTcF interval > 500 ms, Hepatotoxicity, liver injury, increased risk of death, death, Torsade de Pointes, congenital long QT syndrome, hypothyroidism, bradyarrhythmias, uncompensated heart failure, serum calcium below lower limits of normal, serum magnesium below lower limits of normal, serum potassium below lower limits of normal, Clinically significant ventricular arrhythmia, syncope, hepatic-related adverse reactions, fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly, ALT elevation, AST elevation, alkaline phosphatase elevation, bilirubin elevation, aminotransferase elevations with total bilirubin elevation greater than two times the upper limit of normal, aminotransferase elevations greater than eight times the upper limit of normal, aminotransferase elevations greater than five times the upper limit of normal and persist beyond two weeks."
152,NEURACEQ,adverse reactions,"erythema, irritation, pain, death"
153,NEURACEQ,warnings and precautions,"image interpretation errors, false positives, long-term cumulative radiation exposure, increased risk of cancer, errors, severe brain atrophy, motion artifacts, image distortion, <negated>negative scan result precluding the development of brain neuritic beta-amyloid plaques in the future."
154,COMETRIQ,adverse reactions,"Perforations, Fistula, Hemorrhage, Thromboembolic Events, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar erythrodysesthesia syndrome, Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, Diarrhea, Stomatitis, Decreased weight, Decreased appetite, Nausea, Fatigue, Oral pain, Hair color changes, Dysgeusia, Abdominal pain, Constipation, Increased AST, Increased ALT, Lymphopenia, Increased alkaline phosphatase, Hypocalcemia, Neutropenia, Thrombocytopenia, Hypophosphatemia, Hyperbilirubinemia, Asthenia, Dehydration, Arthralgia, Muscle spasms, Musculoskeletal chest pain, Headache, Dizziness, Paresthesia, Peripheral sensory neuropathy, Peripheral neuropathy, Anxiety, Dysphonia, Rash, Dry skin, Alopecia, Erythema, Hyperkeratosis, Hypotension, Hypomagnesemia, Hypokalemia, Hyponatremia, death"
155,COMETRIQ,boxed warnings,"Gastrointestinal perforations, fistula formation, severe hemorrhage, hemoptysis, gastrointestinal hemorrhage, death"
156,COMETRIQ,warnings and precautions,"myocardial infarction, cerebral infarction, arterial thromboembolic events, wound dehiscence, wound complications, hypertension, hypertensive crisis, osteonecrosis of the jaw, Palmar-plantar Erythrodysesthesia syndrome (PPES), proteinuria, nephrotic syndrome, Reversible posterior leukoencephalopathy syndrome (RPLS), Gastrointestinal (GI) perforations, fistulas, tracheal/esophageal fistulas, hemorrhage, hemoptysis, death"
157,AFINITOR,adverse reactions,"non-infectious pneumonitis, infections, angioedema, oral ulceration, renal failure, impaired wound healing, stomatitis, rash, fatigue, diarrhea, edema, abdominal pain, nausea, fever, asthenia, cough, headache, decreased appetite, hyperglycemia, dyspnea, hypercholesterolemia, anemia, leukopenia, thrombocytopenia, lymphopenia, increased aspartate transaminase (AST), increased alanine transaminase (ALT), hypertriglyceridemia, death, vomiting, constipation, dry mouth, edema peripheral, pyrexia, weight decreased, arthralgia, back pain, pain in extremity, dysgeusia, insomnia, epistaxis, pruritus, alopecia, hot flush, hemoglobin decreased, WBC decreased, platelets decreased, glucose increased, cholesterol increased, potassium decreased, creatinine increased, abdominal pain, diabetes mellitus, muscle spasms, dizziness, hypertension, amenorrhea, menorrhagia, menstrual irregularities, vaginal hemorrhage, otitis media, depression, abnormal taste, increased blood luteinizing hormone (LH) levels, increased blood follicle stimulating hormone (FSH) levels, hypersensitivity, ovarian cyst, aggression, agitation, gastroenteritis, pneumonia, sepsis, renal failure, thrombotic events, pulmonary embolus, thrombosis, pleural effusion, pharyngolaryngeal pain, rhinorrhea, hand-foot syndrome (reported as palmar-plantar erythrodysesthesia syndrome), nail disorder, erythema, onychoclasis, skin lesion, acneiform dermatitis, exacerbation of pre-existing diabetes mellitus, new onset of diabetes mellitus, chest pain, chills, impaired wound healing, tachycardia, congestive cardiac failure, jaw pain, hemorrhage, elevated partial thromboplastin time, neutropenia, elevated aspartate transaminase (AST), hypertriglyceridemia, elevated alanine transaminase (ALT), hypophosphatemia, hyperglycemia, cellulitis, acute pancreatitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy"
158,AFINITOR,warnings and precautions,"non-infectious pneumonitis, death, infections, death, angioedema, oral ulceration, mouth ulcers, stomatitis, oral mucositis, renal failure, acute renal failure, death, impaired wound healing, wound-related complications, wound dehiscence, wound infection, incisional hernia, lymphocele, seroma, laboratory test alterations, serum creatinine elevation, urinary protein increase, blood glucose increase, lipid increase, hemoglobin decrease, neutrophils decrease, platelets decrease, vaccinations <negated>, embryo-fetal toxicity, death, pneumonia, mycobacterial infections, bacterial infections, invasive fungal infections, aspergillosis, candidiasis, pneumocystis jiroveci pneumonia (PJP), viral infections, hepatitis B virus reactivation, sepsis, respiratory failure, hepatic failure, hyperglycemia, hyperlipidemia, hypertriglyceridemia, decreased hemoglobin, decreased lymphocytes, decreased neutrophils, decreased platelets."
159,BREO,adverse reactions,"asthma-related death (death), Candida albicans infection, increased risk of pneumonia in COPD, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, influenza, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, pneumonia, arthralgia, pharyngitis, pyrexia, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, rhinitis, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness"
160,BREO,boxed warnings,"asthma-related death, increase in asthma-related deaths, asthma-related hospitalization"
161,BREO,warnings and precautions,"asthma-related death, asthma-related hospitalizations, Candida albicans infection, pneumonia, worsening of infections, tuberculosis <negated>, fungal infections <negated>, bacterial infections <negated>, viral infections <negated>, parasitic infections <negated>, ocular herpes simplex <negated>, chickenpox, measles, impaired adrenal function, hypercorticism, adrenal suppression, paradoxical bronchospasm, cardiovascular disorders, decrease in bone mineral density, glaucoma, cataracts, convulsive disorders <negated>, thyrotoxicosis <negated>, diabetes mellitus <negated>, ketoacidosis <negated>, hypokalemia, hyperglycemia, death"
162,FIRAZYR,adverse reactions,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache, <negated>hypersensitivity, <negated>anaphylactic reactions, death"
163,FIRAZYR,warnings and precautions,"laryngeal attacks, airway obstruction, death"
164,INVOKANA,adverse reactions,"Hypotension, Renal Function Impairment, Hyperkalemia, Hypoglycemia, Genital Mycotic Infections, Hypersensitivity Reactions, Bone Fracture, Increases in Low-Density Lipoprotein (LDL-C), Female genital mycotic infections, Urinary tract infections, Increased urination, Male genital mycotic infections, Vulvovaginal pruritus, Thirst, Constipation, Nausea, Abdominal pain, Fatigue, Asthenia, Pancreatitis, Erythema, Rash, Pruritus, Urticaria, Angioedema, Photosensitivity reactions, Polymorphic light eruption, Sunburn, Volume Depletion-Related Adverse Reactions (e.g., postural dizziness, orthostatic hypotension, syncope, dehydration), Falls, Serum creatinine increase, eGFR decrease, Renal impairment, Acute renal failure, Phimosis, Severe hypoglycemia, Increases in Serum Potassium, Increases in Serum Magnesium, Increases in Serum Phosphate, Increases in Hemoglobin, Decreases in Bone Mineral Density"
165,INVOKANA,warnings and precautions,"hypotension, renal function impairment, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased LDL-C"
166,VORAXAZE,adverse reactions,"Serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor, death"
167,VORAXAZE,warnings and precautions,"serious allergic reactions, anaphylactic reactions, unreliable measurement of methotrexate, erroneous measurement, overestimation of methotrexate concentration, interference with immunoassays, DAMPA interference, death"
168,NESINA,adverse reactions,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure <negated>, severe and disabling arthralgia, acute pancreatitis"
169,NESINA,warnings and precautions,"acute pancreatitis, hypersensitivity reactions, anaphylaxis, angioedema, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic failure, death, hypoglycemia, severe and disabling arthralgia, liver enzyme elevations, fatigue <negated>, anorexia <negated>, right upper abdominal discomfort <negated>, dark urine <negated>, jaundice <negated>"
170,GILENYA,adverse reactions,"Bradyarrhythmia, Atrioventricular Blocks, Infections, Progressive multifocal leukoencephalopathy, Macular Edema, Posterior Reversible Encephalopathy Syndrome, Respiratory Effects, Liver Injury, Headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, Bronchitis, Herpes zoster, Tinea versicolor, Bradycardia, Migraine, Nausea, Asthenia, Alopecia, Actinic keratosis, Blood triglycerides increased, Dyspnea, Vision blurred, Hypertension, Lymphopenia, Leukopenia, Skin papilloma, dizziness <negated>, pneumonia <negated>, eczema <negated>, pruritus <negated>, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, lymphoma"
171,GILENYA,warnings and precautions,"Bradycardia, atrioventricular conduction, infections, Progressive multifocal leukoencephalopathy (PML), Macular edema, Posterior reversible encephalopathy syndrome (PRES), Decrease in pulmonary function tests (PFT), Liver injury, Blood pressure (BP) increase, Bradyarrhythmia, Atrioventricular Blocks, Reduction in Heart Rate, symptomatic bradycardia, hypotension, dizziness, fatigue, palpitations, chest pain, first-degree AV block, second-degree AV block, Mobitz Types I (Wenckebach), 2:1 AV blocks, third-degree AV block, AV block with junctional escape, transient asystole, death, syncope, Risk of Infections, bronchitis, herpes zoster, influenza, sinusitis, pneumonia, Serious infections, Herpes Viral Infections, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, multiorgan failure, Cryptococcal infections, cryptococcal meningitis, Varicella Zoster Virus Antibody Testing/Vaccination, Fingolimod, blurred vision, decreased visual acuity, Dose-dependent reductions in forced expiratory volume over 1 second (FEV1), diffusion lung capacity for carbon monoxide (DLCO), dyspnea, Elevations of liver enzymes, elevation of liver transaminases, Serum transaminase levels, jaundice, dark urine, Fetal Risk, Hypertension, Immune System Effects Following GILENYA Discontinuation."
172,HALAVEN,adverse reactions,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, cytopenias, thrombocytopenia, peripheral motor neuropathy, liver function test abnormalities, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, death"
173,HALAVEN,warnings and precautions,"neutropenia, severe neutropenia, Grade 4 neutropenia, febrile neutropenia, peripheral neuropathy, Grade 3 peripheral neuropathy, Grade 4 peripheral neuropathy, embryo-fetal toxicity, teratogenicity, QT prolongation, hypokalemia, hypomagnesemia, death"
174,INTELENCE,adverse reactions,"Severe skin reactions, hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, Stevens-Johnson syndrome <negated>, drug hypersensitivity reaction <negated>, erythema multiforme <negated>, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, haemorrhagic stroke, death"
175,INTELENCE,warnings and precautions,"Severe skin reactions, potentially life threatening skin reactions, fatal skin reactions, Stevens-Johnson syndrome, hypersensitivity reaction, toxic epidermal necrolysis, erythema multiforme, severe hypersensitivity, severe rash, rash with systemic symptoms, liver transaminase elevations, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), rash, constitutional findings, organ dysfunction, hepatic failure, Grade 3 rash, Grade 4 rash, fever, general malaise, fatigue, muscle aches, joint aches, blisters, oral lesions, conjunctivitis, facial edema, hepatitis, eosinophilia, angioedema, Redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, Immune reconstitution syndrome, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome, death."
176,AMYVID,adverse reactions,"headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing"
177,AMYVID,warnings and precautions,"image interpretation errors, false negatives, radiation risk, errors, extensive brain atrophy, motion artifacts, increased risk of cancer, unintentional radiation exposure, <negated> negative scan result does not preclude the development of brain amyloid in the future"
178,ULESFIA,adverse reactions,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, pain, pruritus, erythema, pyoderma, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation"
179,ULESFIA,warnings and precautions,"gasping syndrome, neonatal toxicity, severe metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death, eye irritation, contact dermatitis, allergic dermatitis, irritant dermatitis"
180,OTEZLA,adverse reactions,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, tension headache, fatigue, insomnia, back pain, depression, bronchitis, tooth abscess, folliculitis, sinus headache, severe worsening of psoriasis (rebound)<negated>"
181,OTEZLA,warnings and precautions,"depression, suicidal thoughts, mood changes, weight decrease, weight loss, suicidal ideation, suicidal behavior, attempted suicide, death"
182,ILARIS,adverse reactions,"infections, upper respiratory tract infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, intra-abdominal abscess, rhinitis, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, gastroenteritis, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, pharyngitis, tonsillitis, urinary tract infection, viral infection, abdominal pain (upper), hypersensitivity reactions, decreased white blood cell counts, neutrophils, platelets, high ALT, high AST, elevated serum bilirubin"
183,ILARIS,warnings and precautions,"serious infections, increased risk of serious infections, recurring infections, predisposition to infections, upper respiratory tract infections, unusual infections, opportunistic infections, aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster, new tuberculosis, reactivation of latent tuberculosis, malignancies <negated>, hypersensitivity reactions, anaphylactic reactions <negated>, immunosuppression, ineffective vaccinations, Macrophage Activation Syndrome (MAS), death"
184,NATAZIA,adverse reactions,"serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, headaches, migraine, breast pain, menstrual disorders, metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding, vomiting, acne, mood changes, depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying, increased weight, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous thromboembolic events, arterial thromboembolic events, pulmonary emboli, cerebral thrombosis, hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms, abdominal pain, vulvovaginal candidiasis, death"
185,NATAZIA,boxed warnings,"serious cardiovascular events, death"
186,NATAZIA,warnings and precautions,"thrombotic event, venous thromboembolism (VTE), arterial thromboses, strokes, myocardial infarctions, thromboembolic disease, retinal vein thrombosis, carcinoma of the breasts, cervical cancer, intraepithelial neoplasia, liver disease, jaundice, hepatic adenomas, intra-abdominal hemorrhage, hepatocellular carcinoma, cholestasis, high blood pressure, gallbladder disease, carbohydrate and lipid metabolic effects, decreased glucose tolerance, dyslipidemia, hypertriglyceridemia, pancreatitis, headache, migraine, breakthrough bleeding, spotting, amenorrhea, oligomenorrhea, intracyclic bleeding, depression, hereditary angioedema, chloasma, death (due to rupture of hepatic adenomas causing intra-abdominal hemorrhage)"
187,DIFICID,adverse reactions,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions (dyspnea, angioedema, rash, pruritus)"
188,DIFICID,warnings and precautions,"angioedema, dyspnea, pruritus, rash, hypersensitivity reactions, drug-resistant bacteria, allergy to other macrolides <negated>, systemic infections <negated>"
189,ONFI,adverse reactions,"Somnolence, Sedation, Potentiation of Sedation, Withdrawal Symptoms, Serious Dermatological Reactions, Physical and Psychological Dependence, Suicidal Behavior and Ideation, Constipation, Pyrexia, Lethargy, Drooling, Vomiting, Dysphagia, Irritability, Fatigue, Upper respiratory tract infection, Pneumonia, Urinary tract infection, Bronchitis, Decreased appetite, Increased appetite, Somnolence or Sedation, Ataxia, Psychomotor hyperactivity, Dysarthria, Aggression, Insomnia, Cough, Anemia, Eosinophilia, Leukopenia, Thrombocytopenia, Diplopia, Vision blurred, Abdominal distention, Hypothermia, Hepatic enzyme increased, Muscle spasms, Agitation, Anxiety, Apathy, Confusional state, Depression, Delirium, Delusion, Hallucination, Urinary retention, Aspiration, Respiratory depression, Rash, Urticaria, Angioedema, Facial and lip edema"
190,ONFI,warnings and precautions,"Somnolence, Sedation, CNS depression, Withdrawal Symptoms, Serious Dermatological Reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, Physical Dependence, Psychological Dependence, Suicidal Behavior, Suicidal Ideation, convulsions, psychosis, hallucinations, behavioral disorder, tremor, anxiety, dysphoria, insomnia, depression, suicidal thoughts, suicidal behavior, mood changes, self-harm, death"
191,TECFIDERA,adverse reactions,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy, lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin urine present, erythema, dyspepsia, aspartate aminotransferase increased, eosinophilia"
192,TECFIDERA,warnings and precautions,"anaphylaxis, angioedema, Progressive multifocal leukoencephalopathy (PML), death, lymphopenia, difficulty breathing, urticaria, swelling of the throat and tongue, progressive weakness, clumsiness of limbs, disturbance of vision, changes in thinking, memory, and orientation, confusion, personality changes, flushing, warmth, redness, itching, burning sensation."
193,DYSPORT,adverse reactions,"Distant Spread of Toxin Effect, Lack of Interchangeability between Botulinum Toxin Products, Spread of Effects from Toxin, Dysphagia, Breathing Difficulties, Facial Anatomy in the Treatment of Glabellar Lines, Pre-existing Neuromuscular Disorders, Human Albumin, Intradermal Immune Reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, disturbance in attention, eyelid disorder, feeling abnormal, muscle atrophy, breathing difficulty, dyspnea, dizziness, muscle atrophy, blood glucose increase, heart rate reduction, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site bruising, injection site reaction, eyelid ptosis, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, contusion, diarrhea, constipation, blood triglycerides increased, cough, hypertension, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, facial paresis, hypoesthesia, erythema, excessive granulation tissue, immunogenicity, antibodies formation, binding antibodies, neutralizing antibodies, sensation of heaviness, gait disturbance, hypertonia."
194,DYSPORT,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
195,DYSPORT,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, exacerbation of clinical effects of treatment, risk for transmission of Creutzfeldt-Jakob disease (CJD) <negated>, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death, severe dysphagia, aspiration, weakening of neck muscles, respiratory failure, facial anatomy alterations, excessive weakness, atrophy, marked facial asymmetry, inflammation at the injection site, excessive dermatochalasis, deep dermal scarring, thick sebaceous skin, eyelid ptosis, peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, neuromuscular junction disorders, severe dysphagia <negated>, respiratory compromise <negated>, immune reaction <negated>, transmission of viral diseases <negated>"
196,ZYTIGA,adverse reactions,"Hypertension, Hypokalemia, Fluid Retention, Mineralocorticoid Excess, Adrenocortical Insufficiency, Hepatotoxicity, Fatigue, Joint Swelling, Joint Discomfort, Edema, Hot Flush, Diarrhea, Vomiting, Cough, Dyspnea, Urinary Tract Infection, Contusion, Anemia, Elevated Alkaline Phosphatase, Hypertriglyceridemia, Lymphopenia, Hypercholesterolemia, Hyperglycemia, Elevated AST, Hypophosphatemia, Elevated ALT, Muscle Discomfort, Dyspepsia, Upper Respiratory Tract Infection, Urinary Frequency, Nocturia, Fractures, Arrhythmia, Chest Pain, Chest Discomfort, Cardiac Failure, Pyrexia, Groin Pain, Constipation, Insomnia, Falls, Nasopharyngitis, Hematuria, Rash, Hypernatremia, Myocardial Ischemia, Myocardial Infarction, Non-infectious Pneumonitis, Myopathy, Rhabdomyolysis, Cardiovascular Adverse Reactions, Cardiac Failure, Arrhythmias, Sudden Death, Cardiorespiratory Arrest, death"
197,ZYTIGA,warnings and precautions,"Mineralocorticoid excess, cardiovascular disease, LVEF < 50%, NYHA Class III heart failure, NYHA Class IV heart failure, hypertension, hypokalemia, fluid retention, adrenocortical insufficiency, hepatotoxicity, increases in liver enzymes, drug interruption, dose modification, discontinuation, liver function, grade 3 hypertension, grade 4 hypertension, grade 3 hypokalemia, grade 4 hypokalemia, grade 3 edema, grade 4 edema, myocardial infarction, ventricular arrhythmia, left ventricular ejection fraction <50%, New York Heart Association (NYHA) Class III heart failure, NYHA Class IV heart failure, NYHA Class II heart failure, adrenal insufficiency, prednisone withdrawal, concurrent infection, stress, ALT increase, AST increase, liver enzyme increases, serum transaminases elevation, bilirubin levels elevation, moderate hepatic impairment, AST or ALT rise above five times the ULN, bilirubin rises above three times the ULN, AST or ALT greater than or equal to 20* ULN, bilirubin greater than or equal to 10* ULN, death <negated>."
198,DUAVEE,adverse reactions,"Cardiovascular Disorders, Malignant Neoplasms, Gallbladder Disease, Hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, hot flush, venous thromboembolism, deep venous thrombosis, pulmonary embolism, retinal vein thrombosis, death"
199,DUAVEE,boxed warnings,"endometrial cancer, cardiovascular disorders, probable dementia, stroke, deep vein thrombosis (DVT), blood clots, cancer of the uterus, heart disease <negated>, heart attacks <negated>, dementia (decline in brain function), strokes, blood clots, dementia, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of asthma <negated>, worsening of diabetes <negated>, worsening of epilepsy <negated>, worsening of migraines <negated>, worsening of porphyria <negated>, worsening of lupus <negated>, worsening of liver problems <negated>, breast cancer, cancer of the ovary, muscle spasms, nausea, diarrhea, upset stomach, abdominal pain, throat pain, dizziness, neck pain, breast lumps, unusual vaginal bleeding, changes in vision, speech changes, severe headaches, severe chest pains, leg pains, shortness of breath, weakness, fatigue, death"
200,DUAVEE,warnings and precautions,"cardiovascular disorders, venous thromboembolism, pulmonary embolism, stroke, retinal vascular thrombosis, malignant neoplasms, endometrial cancer, breast cancer, ovarian cancer, gallbladder disease, loss of vision <negated>, severe hypertriglyceridemia, cholestatic jaundice, thyroid function <negated>, probable dementia, visual abnormalities, elevated blood pressure <negated>, hypertriglyceridemia, hepatic impairment, past history of cholestatic jaundice, hypothyroidism, fluid retention, hypocalcemia, hereditary angioedema, exacerbation of asthma <negated>, exacerbation of diabetes mellitus <negated>, exacerbation of epilepsy <negated>, exacerbation of migraine <negated>, exacerbation of porphyria <negated>, exacerbation of systemic lupus erythematosus <negated>, hepatic hemangiomas <negated>, impaired glucose tolerance"
201,SAPHRIS,adverse reactions,"Dementia-Related Psychosis, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, Hypersensitivity Reactions, oral ulcers, blisters, peeling/sloughing, inflammation, Orthostatic Hypotension, Syncope, Hemodynamic Effects, Leukopenia, Neutropenia, Agranulocytosis, QT Interval Prolongation, Hyperprolactinemia, Seizures, Cognitive Impairment, Motor Impairment, Body Temperature Regulation, Suicide, Dysphagia, akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms, increased weight, dysgeusia, oral paresthesia, nausea, increased appetite, fatigue, constipation, dry mouth, salivary hypersecretion, stomach discomfort, vomiting, irritability, insomnia, hypertension, anxiety, dyspepsia, toothache, arthralgia, pain in extremity, headache, depression, tachycardia, heart rate increased, glossodynia, muscle strain, hyperinsulinemia, ALT increased, AST increased, dehydration, myalgia, parkinsonism, suicidal ideation, anger, dysmenorrhea, oropharyngeal pain, nasal congestion, dyspnea, rash, edema peripheral, dystonia, bradykinesia, dyskinesia, oromandibular dystonia, muscle contractions involuntary, muscle twitching, musculoskeletal stiffness, protrusion tongue, resting tremor, tremor, galactorrhea, gynecomastia, diplopia, vision blurred, gastroesophageal reflux disease, fall, photosensitivity reaction, enuresis, oral ulcers, blisters, peeling/sloughing, inflammation, choking, oropharyngeal muscular dysfunction, hypoesthesia, death (due to mention of fatal events)."
202,SAPHRIS,boxed warnings,"increased mortality, death, dementia-related psychosis"
203,SAPHRIS,warnings and precautions,"cerebrovascular adverse events, stroke, transient ischemic attack, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, hyperglycemia, dyslipidemia, weight gain, anaphylaxis, angioedema, Orthostatic Hypotension, Syncope, dizziness, tachycardia, bradycardia, Leukopenia, Neutropenia, Agranulocytosis, QT Prolongation, Seizures, Cognitive Impairment, Motor Impairment, Suicide, death, Hypersensitivity Reactions, hypotension, swollen tongue, dyspnea, wheezing, rash, Hyperprolactinemia, Galactorrhea, amenorrhea, gynecomastia, impotence, Body Temperature Regulation, Dysphagia, aspiration pneumonia, myocardial infarction, unstable heart disease, cardiac dysrhythmia, hyperpyrexia, muscle rigidity, altered mental status, autonomic instability, irregular pulse, blood pressure, diaphoresis, elevated creatine phosphokinase, myoglobinuria, rhabdomyolysis, acute renal failure, systemic infection, extrapyramidal signs and symptoms (EPS), central anticholinergic toxicity, heat stroke, drug fever, primary central nervous system pathology, diabetes mellitus, polydipsia, polyuria, polyphagia, weakness, ketoacidosis, hyperosmolar coma, fasting glucose changes, lipid alterations, total cholesterol changes, LDL changes, HDL changes, fasting triglycerides changes, body weight changes, somnolence, sedation, hypersomnia, pyrexia, feeling hot"
204,DUREZOL,adverse reactions,"elevated intraocular pressure, optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection, herpes simplex, perforation of the globe, corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort or irritation, corneal pigmentation and striae, episcleritis, eye pruritis, eyelid irritation and crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal and conjunctival hyperemia, dry eye, iridocyclitis"
205,DUREZOL,warnings and precautions,"Intraocular pressure increase, glaucoma, damage to the optic nerve, defects in visual acuity, defects in fields of vision, cataracts, posterior subcapsular cataract formation, delayed healing, bleb formation, corneal or scleral thinning, corneal or scleral perforations, bacterial infections, secondary ocular infections, viral infections, exacerbation of viral infections, herpes simplex exacerbation, fungal infections, corneal fungal infections, corneal ulceration, fungus invasion."
206,ZYDELIG,adverse reactions,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, sepsis, febrile neutropenia, elevated transaminases, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, bronchitis, sinusitis, urinary tract infection, arthralgia, lymphocyte count decreased, lymphocyte count increased, GGT increased, hypoglycemia, hyponatremia, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, hemoglobin decreased, platelets decreased"
207,ZYDELIG,boxed warnings,"hepatic toxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, death"
208,ZYDELIG,warnings and precautions,"severe cutaneous reactions, anaphylaxis, neutropenia, embryo-fetal toxicity, hepatotoxicity, death, elevations in ALT, elevations in AST, severe diarrhea, colitis, pneumonitis, intestinal perforation, toxic epidermal necrolysis (TEN), dermatitis exfoliative, rash, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder, serious allergic reactions, Grade 3 neutropenia, Grade 4 neutropenia, teratogenic effects"
209,KALBITOR,adverse reactions,"Hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, erythema, pain, irritation, urticaria, bruising, anti-ecallantide antibodies, neutralizing antibodies, anti-ecallantide IgE antibodies, anti-P. pastoris IgE antibodies."
210,KALBITOR,boxed warnings,"anaphylaxis, hypersensitivity reactions, hereditary angioedema, clinical hypersensitivity <negated>"
211,KALBITOR,warnings and precautions,"anaphylaxis, hypersensitivity reactions, chest discomfort, flushing, pharyngeal edema, pruritus, rhinorrhea, sneezing, nasal congestion, throat irritation, urticaria, wheezing, hypotension, rash"
212,ADCETRIS,adverse reactions,"Peripheral Neuropathy, Anaphylaxis, Infusion Reactions, Hematologic Toxicities, Serious Infections, Opportunistic Infections, Tumor Lysis Syndrome, Severe Renal Impairment, Moderate Hepatic Impairment, Severe Hepatic Impairment, Hepatotoxicity, Progressive Multifocal Leukoencephalopathy, Pulmonary Toxicity, Serious Dermatologic Reactions, Neutropenia, Peripheral Sensory Neuropathy, Fatigue, Nausea, Anemia, Upper Respiratory Tract Infection, Diarrhea, Pyrexia, Rash, Thrombocytopenia, Cough, Vomiting, Peripheral Motor Neuropathy, Lymphadenopathy, Headache, Dizziness, Chills, Pain, Edema Peripheral, Constipation, Pruritus, Alopecia, Night Sweats, Dry Skin, Dyspnea, Oropharyngeal Pain, Arthralgia, Myalgia, Back Pain, Pain in Extremity, Muscle Spasms, Insomnia, Anxiety, Decreased Appetite, Weight Decreased, Febrile Neutropenia, Hyperglycemia, Pancreatitis <negated>, Noninfectious Pulmonary Toxicity, Pneumonitis, Interstitial Lung Disease, ARDS, Toxic Epidermal Necrolysis, Death"
213,ADCETRIS,boxed warnings,"progressive multifocal leukoencephalopathy, JC virus infection, death"
214,ADCETRIS,warnings and precautions,"Peripheral neuropathy, Anaphylaxis, Infusion reactions, Hematologic toxicities, Serious infections, Opportunistic infections, Tumor lysis syndrome, Hepatotoxicity, Pulmonary Toxicity, Serious dermatologic reactions, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Embryo-fetal toxicity, Neutropenia, Thrombocytopenia, Anemia, Febrile neutropenia, Pneumonia, Bacteremia, Sepsis, Septic shock <negated>, Progressive Multifocal Leukoencephalopathy, PML, Pneumonitis, Interstitial lung disease, Acute respiratory distress syndrome (ARDS), Death"
215,BESIVANCE,adverse reactions,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
216,BESIVANCE,warnings and precautions,"Growth of Resistant Organisms with Prolonged Use, overgrowth of non-susceptible organisms, fungi, super-infection, signs or symptoms of bacterial conjunctivitis"
217,CLEVIPREX,adverse reactions,"headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, hypotension, decreased oxygen saturation, reflex tachycardia"
218,CLEVIPREX,warnings and precautions,"hypotension, reflex tachycardia, negative inotropic effects, exacerbate heart failure, rebound hypertension, lipid intake restrictions<negated>, beta-blocker withdrawal<negated>"
219,XTANDI,adverse reactions,"asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, seizure <negated>, asthenic conditions, peripheral edema, musculoskeletal pain, muscular weakness, musculoskeletal stiffness, gastrointestinal disorders, vascular disorders, nervous system disorders, spinal cord compression, cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, infections and infestations, lower respiratory tract and lung infection, psychiatric disorders, insomnia, anxiety, renal and urinary disorders, hematuria, pollakiuria, injury, poisoning and procedural complications, fall, non-pathologic fractures, skin and subcutaneous tissue disorders, pruritus, dry skin, respiratory disorders, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, laboratory abnormalities, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections, falls and fall-related injuries, hypertension, death (due to infections or sepsis)."
220,XTANDI,warnings and precautions,"seizure, death"
221,BOSULIF,adverse reactions,"Gastrointestinal toxicity, Myelosuppression, Hepatic toxicity, Fluid retention, Renal toxicity, Diarrhea, Nausea, Thrombocytopenia, Vomiting, Abdominal pain, Rash, Anemia, Pyrexia, Fatigue, Anaphylactic shock, Increased alanine aminotransferase, Headache, Cough, Increased aspartate aminotransferase, Neutropenia, Edema, Arthralgia, Decreased appetite, Respiratory tract infection, Nasopharyngitis, Back pain, Asthenia, Pruritus, Dizziness, Dyspnea, QTcF interval prolongation, Platelet Count Low, Absolute Neutrophil Count Low, Hemoglobin Low, SGPT/ALT greater than 5.0*ULN, SGOT/AST greater than 5.0*ULN, Lipase greater than 2*ULN, Phosphorus Low, Total Bilirubin greater than 3.0*ULN, Febrile neutropenia, Pericardial effusion, Pericarditis, Tinnitus, Gastritis, Acute pancreatitis, Gastrointestinal hemorrhage, Chest pain, Pain, Hepatotoxicity, Abnormal hepatic function, Liver injury, Drug hypersensitivity, Pneumonia, Influenza, Bronchitis, Electrocardiogram QT prolonged, Increased blood creatine phosphokinase, Increased blood creatinine, Hyperkalemia, Dehydration, Myalgia, Dysgeusia, Acute renal failure, Renal failure, Pleural effusion, Acute pulmonary edema, Respiratory failure, Pulmonary hypertension, Urticaria, Acne, Erythema multiforme, Exfoliative rash, Drug eruption"
222,BOSULIF,warnings and precautions,"Gastrointestinal Toxicity, Diarrhea, Nausea, Vomiting, Abdominal Pain, Myelosuppression, Thrombocytopenia, Anemia, Neutropenia, Hepatic Toxicity, Drug Induced Liver Injury, ALT Elevation, AST Elevation, Fluid Retention, Pericardial Effusion, Pleural Effusion, Pulmonary Edema, Peripheral Edema, Renal Toxicity, Decline in eGFR, Kidney Failure, Embryofetal Toxicity, Fetal Harm"
223,CARBAGLU,adverse reactions,"Infections, vomiting, abdominal pain, pyrexia, tonsillitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash"
224,CARBAGLU,warnings and precautions,"Hyperammonemia, injury to the brain, death, brain injury/damage"
225,SIMPONI,adverse reactions,"serious infections, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, malignancies, liver enzyme elevations, acute liver failure, autoimmune disorders, lupus-like syndrome, administration reactions, rash, immunogenicity, antibodies to SIMPONI ARIA, neutralizing antibodies, upper respiratory tract infection, viral infections, bronchitis, hypertension, pyrexia, leukopenia, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, dizziness, paresthesia, constipation, melanoma, serious systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, interstitial lung disease, skin exfoliation, bullous skin reactions"
226,SIMPONI,boxed warnings,"serious infections, hospitalization, death, tuberculosis (TB), bacterial sepsis, invasive fungal infections, histoplasmosis, opportunistic infections, lymphoma, malignancies, active tuberculosis, reactivation of latent tuberculosis, disseminated disease, extrapulmonary disease, invasive fungal infections, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, Legionella, Listeria"
227,SIMPONI,warnings and precautions,"serious infections, invasive fungal infections, hepatitis B reactivation, malignancies, lymphoma, heart failure, demyelinating disease, hypersensitivity reactions, anaphylaxis, opportunistic infections, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, tuberculosis, sepsis, tuberculosis reactivation, melanoma, Merkel cell carcinoma, congestive heart failure, central nervous system demyelinating disorders, multiple sclerosis, peripheral demyelinating disorders, Guillain-Barre syndrome, central demyelination, optic neuritis, peripheral demyelinating polyneuropathy, pancytopenia, leukopenia, neutropenia, aplastic anemia, thrombocytopenia, death"
228,BENLYSTA,adverse reactions,"Mortality, Serious Infections, Malignancy, Hypersensitivity Reactions, Anaphylaxis, Infusion Reactions, Depression, Nausea, Diarrhea, Pyrexia, Nasopharyngitis, Bronchitis, Insomnia, Pain in extremity, Migraine, Pharyngitis, Cystitis, Leukopenia, Gastroenteritis viral, Fatal anaphylaxis, death"
229,BENLYSTA,warnings and precautions,"death, serious infections, fatal infections, Progressive Multifocal Leukoencephalopathy (PML), hypersensitivity reactions, anaphylaxis, fatal reactions, depression, suicidality, upper respiratory tract infection, urinary tract infection, nasopharyngitis, sinusitis, bronchitis, influenza, pneumonia, cellulitis, malignancies, non-melanoma skin cancers, rash, nausea, fatigue, myalgia, headache, facial edema, infusion reactions, bradycardia, hypotension, skin reactions, insomnia, anxiety, serious psychiatric events, serious depression, suicidal behavior, <negated>live vaccines concurrent with BENLYSTA, <negated>concomitant use with other biologic therapies, <negated>concomitant use with intravenous cyclophosphamide"
230,TOVIAZ,adverse reactions,"dry mouth, constipation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus, angina, chest pain, gastroenteritis, QT prolongation on ECG, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation, death"
231,TOVIAZ,warnings and precautions,"Angioedema, urinary retention, severe constipation, narrow-angle glaucoma, somnolence, headache, dizziness, death"
232,ENTEREG,adverse reactions,dyspepsia
233,ENTEREG,boxed warnings,"myocardial infarction, death"
234,ENTEREG,warnings and precautions,"myocardial infarctions, abdominal pain, nausea and vomiting, diarrhea, serious adverse reactions, death"
235,VIZAMYL,adverse reactions,"flushing, increased blood pressure, headache, nausea, dizziness, hypersensitivity reaction, dyspnea, chest pressure, death"
236,VIZAMYL,warnings and precautions,"hypersensitivity reactions, flushing, dyspnea, image interpretation errors, false positives, radiation risk, cancer, <negated> negative scan result"
237,AMPYRA,adverse reactions,"Seizures, Anaphylaxis, Urinary Tract Infections, urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, confusional state, death"
238,AMPYRA,warnings and precautions,"seizures, anaphylaxis, respiratory compromise, urticaria, angioedema, urinary tract infections"
